Key facts
- This page summarizes Stewart Abbot's Form 4 filing for Adicet Bio, Inc. (ACET).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 Jun 2021, 16:28.
Stewart Abbot - 11 Jun 2021 Form 4 Insider Report for Adicet Bio, Inc. (ACET)
- Reporting relationship
- Former Chief Scientific and Operating Officer
- Issuer ticker
- ACET
- Reported as of
- 11 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Jun 2021, 16:28:37 UTC
- Next SEC filing
- 20 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nick Harvey, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Stewart Abbot filed Form 4 for Adicet Bio, Inc. (ACET) on 14 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ACET
transaction
Derivative
Non-Qualified Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +5,000
- Change %
- Price
- $0.000000
- Shares after
- 5,000
- Date
- 11 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $11.75
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares underlying this option shall vest in twelve equal monthly installments commencing on June 11, 2021.
SEC remarks
Former Chief Scientific and Operating Officer